Central obesity

There are 408 papers on central obesity in aging research: 13 trials and 341 observational studies in people, 2 in animals, 51 reviews.

Disease

408 papers study it301 more mention it135 findings

64 new papers in 30 daysSee all 709 papers on central obesity

“central obesity (Beta = 0.481; p = 0.005)”
Predictors of weight loss in patients with obesity treated with a Very Low-Calorie Ketogenic DietFrontiers in nutrition2023doi:10.3389/fnut.2023.1058364
  • Human trial13
  • Humans341
  • Animals2
  • In silico1

Interventions

5

Dietary approaches to stop hypertension

downin humans1

1 study
  1. Dietary approaches to stop hypertension is linked with lower central obesity in humans (comparing high versus low DASH scores) (aPR 0.79, 95% CI 0.64-0.98).

    “they were associated with lower prevalence of central obesity (waist circumference), a component of MetS (aPR: 0.79, 95% CI: 0.64-0.98).”

    Humanscomparing high versus low DASH scoresn = 3,332

    Dietary Approaches to Stop Hypertension Diet Pattern and Metabolic Syndrome Prevalence Among U.S. Young Adults: Cross-Sectional Study From the NHANES 2011-2018

    Health science reports

More on Dietary approaches to stop hypertension

Heat stress

no changein humans1

1 study
  1. Heat stress was not clearly linked with central obesity in northern or eastern Taiwan (no significant associations).

    “However, no significant associations were observed between central obesity with WBGT in northern or eastern Taiwan.”

    Humansin northern or eastern Taiwan

    Opposite Association Between Wet-Bulb Globe Temperature With Central Obesity in Different Geographic Regions in Taiwan

    International journal of endocrinology

More on Heat stress

Physical activity

downin humans1

1 study
  1. Physical activity is linked with lower central obesity in humans (decreased functional capacity) (50.0% vs 70.7% central obesity, 7.7% vs 26.8% hypertension).

    “Central obesity and hypertension prevalence were significantly higher in the non-active group (70.7% and 26.8%, respectively), compared to the active group (50.0% and 7.7%, respectively).”

    Humansdecreased functional capacityn = 110

    Prevalence of Metabolic Syndrome and Association with Physical Activity and Frailty Status in Spanish Older Adults with Decreased Functional Capacity: A Cross-Sectional Study

    Nutrients

More on Physical activity

Dietary magnesium intake

downin humans1

1 study
  1. Dietary magnesium intake is linked with lower central obesity in humans (reduced by 18%).

    “Central obesity, elevated TG, elevated blood pressure and elevated blood glucose were reduced by 18%, 41%, 20% and 42%, respectively.”

    Humans

    Relationship between Dietary Magnesium Intake and Metabolic Syndrome

    Nutrients

More on Dietary magnesium intake

Residential greenness

no changein humans1

1 study
  1. Residential greenness was not clearly linked with central obesity in humans.

    “No significant association was found for greenness and central obesity prevalence.”

    Humans

    Association between residential greenness and overweight/obesity among rural adults in northwestern China

    Environmental research

More on Residential greenness

Effects

8

Telomere length

downin humans2

2 studies
  1. Central obesity is linked with lower telomere length in humans (-0.316 (95% CI: -0.437, -0.196)).

    “Each one-unit increment in WC, WHR and WHtR were related to a 0.316 (95% confidence interval (CI): -0.437, -0.196), 0.323 (95% CI: -0.513, -0.134) and 0.277 (95% CI: -0.400, -0.153) decrease in relative TL”

    Humansn = 5,091

    Mediation Effect of Platelet Traits on Associations of Central Obesity with Aging Biomarkers in Rural Adults of Henan, China

    Nutrients

  2. Central obesity is linked with lower telomere length in humans (ß=-0.17 [-0.30, -0.03], P=0.017).

    “increased central obesity (ß=-0.17 [-0.30, -0.03], P=0.017) were all significantly associated with shorter telomeres.”

    Humans

    Association between objectively measured physical activity, chronic stress and leukocyte telomere length

    The Journal of sports medicine and physical fitness

More on Telomere length

Incident type 2 diabetes

mediatesin humans1

1 study
  1. Central obesity is linked with incident type 2 diabetes in humans (21.4-23.5% of the total effect mediated).

    “Central obesity mediated 21.4-23.5% of the total effect of depressive symptoms burden on T2D risk.”

    HumansMediation of the association between menopausal-transition depressive symptom burden and postmenopausal type 2 diabetesfemalesn = 1,719

    Depressive Symptoms and Central Obesity Over the Menopausal Transition and the Development of Type 2 Diabetes Later in Life: Decomposing Direct and Indirect Effects

    Biopsychosocial science and medicine

More on Incident type 2 diabetes

Multiple long-term conditions

mediatesin humans1

1 study
  1. Central obesity is linked with multiple long-term conditions in humans (mediation of the association between socioeconomic position and incident MLTC) (13% mediated (10%, 16%)).

    “The proportion mediated by overall obesity was 8% (6%, 11%) and central obesity was 13% (10%, 16%).”

    Humansmediation of the association between socioeconomic position and incident MLTCfive yearsn = 194,038

    Obesity linked to education gaps in long-term illness rates

    Scientific reports

More on Multiple long-term conditions

Cognitive function

downin humans1

1 study
  1. Central obesity impairs cognitive function in humans.

    “Central obesity (CO), characterized by excessive visceral adipose tissue (VAT) accumulation, is increasingly recognized as a risk factor for cognitive decline, dementia, and Alzheimer's disease (AD).”

    Review

    Microbiota-Gut-Brain Axis Mechanisms in Cognitive Impairment Associated with Central Obesity

    Current obesity reports

Osteoporosis

no changein humans1OR 0.913

1 study
  1. Central obesity showed no clear effect on osteoporosis in humans (OR 0.913, 95% CI 0.761–1.096).

    “No significant association was observed between central obesity and osteoporosis”

    Review

    The effect of overweight or obesity on osteoporosis: A systematic review and meta-analysis

    Clinical nutrition (Edinburgh, Scotland)

More on Osteoporosis

Mortality

no changein humans1

1 study
  1. Central obesity was not clearly linked with mortality in patients with chronic kidney disease (1.05; 0.51, 2.15).

    “whereas central obesity (n = 82) was not associated with mortality (1.05; 0.51, 2.15) in the Cox regression analyses.”

    Humansin patients with chronic kidney disease2-yn = 82

    The Association of Sarcopenia and Central Obesity with Mortality Risk in Patients with Chronic Kidney Disease - a 2-Year Observational Study

    Current developments in nutrition

Mitochondrial DNA copy number

downin humans1

1 study
  1. Central obesity is linked with lower mitochondrial DNA copy number in humans (-0.102 (95% CI: -0.197, -0.007)).

    “or a 0.102 (95% CI: -0.197, -0.007), 0.109 (95% CI: -0.258, -0.041) and 0.101 (95% CI: -0.199, -0.004) decrease in relative mtDNA-CN.”

    Humansn = 5,091

    Mediation Effect of Platelet Traits on Associations of Central Obesity with Aging Biomarkers in Rural Adults of Henan, China

    Nutrients

More on Mitochondrial DNA copy number

Dehydroepiandrosterone sulfate

downin humans1

1 study
  1. Central obesity is linked with lower dehydroepiandrosterone sulfate in humans.

    “Central adiposity was associated with lower DHEAS levels at follow-up, while elevated body mass index was not.”

    Humansmales

    Body mass index, waist circumference and waist to hip ratio and change in sex steroid hormones: the Massachusetts Male Ageing Study

    Clinical endocrinology

More on Dehydroepiandrosterone sulfate

Upstream

4

Rural residence

downin humans1OR 0.43

1 study
  1. rural residence is linked with less central obesity in humans (fully adjusted model) (fully adjusted OR 0.43, 95% CI 0.30-0.64).

    “Rural residence was strongly protective against central obesity across all models (fully adjusted OR, 0.43; 95% CI, 0.30-0.64).”

    Humansfully adjusted model

    Socioeconomic inequalities in obesity among older adults in the Astana region of Kazakhstan: evidence of a reversed socioeconomic gradient

    Frontiers in public health

PhenoAge

mediatesin humans1

1 study
  1. PhenoAge is linked with central obesity in humans (DI-GM's protective effect on central obesity) (22.63%).

    “Biological aging mediated 20.12% (KDM), 22.63% (PA), and 1.68% (HD) of DI-GM's protective effects (p < 0.05)”

    HumansDI-GM's protective effect on central obesityn = 17,012

    Joint Association of Diet Index for Gut Microbiota and MVPA With Central Obesity: The Mediating Role of Biological Age

    Food science & nutrition

More on PhenoAge

Klemera-Doubal biological age

mediatesin humans1

1 study
  1. Klemera-Doubal biological age is linked with central obesity in humans (DI-GM's protective effect on central obesity) (20.12%).

    “Biological aging mediated 20.12% (KDM), 22.63% (PA), and 1.68% (HD) of DI-GM's protective effects (p < 0.05), but not MVPA's effects.”

    HumansDI-GM's protective effect on central obesityn = 17,012

    Joint Association of Diet Index for Gut Microbiota and MVPA With Central Obesity: The Mediating Role of Biological Age

    Food science & nutrition

More on Klemera-Doubal biological age

FGF21

upin mice1

1 study
  1. FGF21 increases central obesity in mice (shown by liver-specific knockout in ovariectomized mice).

    “thus abrogating OVX-induced obesity in females”

    Animalsshown by liver-specific knockout in ovariectomized micevisceral adipose tissuefemales

    Hepatic-Specific FGF21 Knockout Abrogates Ovariectomy-Induced Obesity by Reversing Corticosterone Production

    International journal of molecular sciences

More on FGF21

Associations

88

Hypertension

upin humans10OR 2.09–3.06

10 studies
  1. Central obesity is associated with hypertension in humans (Adjusted analysis; association not statistically significant) (aPR = 1.47; 95% CI: 0.90–2.40; p = 0.126).

    “central obesity (aPR = 1.47; 95% CI: 0.90–2.40; p = 0.126) were not significantly associated with hypertension after adjustment.”

    HumansAdjusted analysis; association not statistically significantn = 231

    Hypertension and Associated Factors Among Employees of a Tertiary Academic–Healthcare Institution in Southwestern Uganda

    International journal of hypertension

  2. Central obesity is associated with hypertension in humans (adjusted analysis in the retained rural Black adult cohort) (Follow-up aOR 2.60, 95% CI 1.69–3.99; baseline aOR 2.92, 95% CI 1.72–4.96).

    “with age, central obesity, and diabetes as consistent risk factors.”

    Humansadjusted analysis in the retained rural Black adult cohortfive yearsn = 518

    Hypertension prevalence and risk factors in a retained high-risk cohort of rural Black adults: a five-year follow-up study in Limpopo Province, South Africa

    Scientific reports

  3. Central obesity is linked with a higher risk of hypertension in humans (aPR 1.52, 95% CI 1.49-1.55).

    “Women with central obesity had a significantly higher prevalence ratio of hypertension (aPR = 1.52; 95 percent CI:1.49-1.55).”

    Humansfemalesn = 6,450

    Association between central obesity and hypertension among women aged > 18 years based on the 2023 Indonesian health survey

    Women & health

  4. Hypertension is associated with central obesity in humans (living with hypertension) (AOR 1.72, 95%CI 1.36-2.18).

    “and those living with hypertension (AOR = 1.72, 95%CI: 1.36-2.18).”

    Humansliving with hypertension

    Gender disparities in central obesity in Cape Verde: analysis of the 2020 WHO STEPS survey

    Scientific reports

  5. Central obesity is associated with hypertension in urban areas (AOR 2.031, 95% CI 1.477–2.793).

    “In urban areas, hypertension was associated with older age (AOR =1.366; 95% CI: 1.043–1.789), female sex (AOR=1.681;95% CI: 1.198–2.359), central obesity based on waist circumference (AOR=2.031; 95% CI:1.477–2.793)”

    Humansin urban areas

    Urban–Rural Disparities in Metabolic Risk Factors for Hypertension Among the Elderly in Indonesia

    Kesmas National Public Health Journal

  6. Central obesity is linked with a higher risk of hypertension in Han majority and Ha Ni ethnic minority older adults (OR = 2.09, 95% CI: 1.62-2.69 vs. OR = 2.66, 95% CI: 1.88-3.76).

    “participants with central obesity (OR = 2.09, 95% CI: 1.62-2.69 vs. OR = 2.66, 95% CI: 1.88-3.76) had a higher risk of hypertension”

    Humansin Han majority and Ha Ni ethnic minority older adults

    Ethnic disparities and lifestyle determinants in the prevalence of cardiovascular disease among Han majority and Ha Ni ethnic minority older adults in rural Southwest China

    BMC cardiovascular disorders

  7. Central obesity predicts hypertension in humans (Central obesity assessed by waist-to-height ratio).

    “General obesity and central obesity by WHtR significantly predicted HTN among men and women, but not central obesity by WC.”

    HumansCentral obesity assessed by waist-to-height ratiomen and womensn = 1,000

    Hypertension and Obesity in Dakar, Senegal

    PloS one

  8. Central obesity is associated with hypertension in humans (Central obesity defined by waist circumference; adjusted for gender and age).

    “overweight, obesity and centrality obesity (calculated according to waist circumference) were risk factors for hypertension”

    HumansCentral obesity defined by waist circumference; adjusted for gender and agen = 2,033

    Relationship between hypertension and body mass index, waist circumference and waist-hip ratio in middle-aged and elderly residents

    Zhonghua liu xing bing xue za zhi = Zhonghua liuxingbingxue zazhi

  9. Central obesity is associated with hypertension in humans (Normal BMI; adjusted for gender, age, and BMI) (PR 1.337 (95% CI 1.224–1.461)).

    “Hypertension, diabetes and hyperlipidemia were significantly associated with central obesity among adults with normal BMI”

    HumansNormal BMI; adjusted for gender, age, and BMI

    Prevalence of Central Obesity among Adults with Normal BMI and Its Association with Metabolic Diseases in Northeast China

    PloS one

  10. Central obesity is associated with hypertension in humans (Nigeria) (OR 3.06, 95% CI 1.94–4.82).

    “Hypertension was associated with age ≥50 years (4.39, 3.14–6.14), central obesity (3.06, 1.94–4.82)”

    ReviewNigeria

    Factors associated with hypertension in Nigeria: a systematic review and m​eta-analysis with an exploratory risk stratification framework

    Frontiers in cardiovascular medicine

More on Hypertension

Female sex

upin humans4

4 studies
  1. Female sex is associated with central obesity in humans (Adults with HIV receiving dolutegravir-based first-line antiretroviral therapy) (aOR 4.9, 95% CI 2.9–8.3).

    “Being female (aOR = 4.9; 95% CI: 2.9-8.3)”

    HumansAdults with HIV receiving dolutegravir-based first-line antiretroviral therapyn = 433

    Prevalence and associated factors of overweight/obesity and central obesity among adults receiving dolutegravir-based first-line treatment in health facilities at hawassa city administration, sidama region

    Obesity pillars

  2. Female sex is associated with central obesity in humans (AOR = 2.5 (95% CI: 1.5, 4.2)).

    “being female (AOR=2.5, 95% CI: 1.5, 4.2)”

    Humans

    Magnitude of Central Obesity and Its Associated Factors among Civil Servants in West Gojjam Zone District Government Offices, Northwest Ethiopia

    European Journal of Preventive Medicine

  3. Female sex is associated with central obesity in humans (women vs men) (16.15% point higher probability, 95%CI 11.84%-20.46%).

    “women had a 16.15% point higher probability of central obesity compared with men (95%CI: 11.84%-20.46%; p < 0.001).”

    Humanswomen vs men

    Gender disparities in central obesity in Cape Verde: analysis of the 2020 WHO STEPS survey

    Scientific reports

  4. Female sex is associated with central obesity in humans (Rural Punjab, India; assessed using WC and WHR).

    “Females had significantly higher obesity risk (WC and WHR) than males.”

    HumansRural Punjab, India; assessed using WC and WHRn = 2,349

    Obesity in Low- and Middle-Income Countries: Sex-Specific Sociocultural Determinants in High-Risk Rural Punjab, India

    American journal of human biology : the official journal of the Human Biology Council

Diabetes mellitus

upin humans4

4 studies
  1. Central obesity is associated with diabetes mellitus in humans across both clusters.

    “Central obesity in females consistently scaled up prevalence across both clusters.”

    Humansacross both clustersfemales

    The great diabetic divide of india: findings from geospatial analysis of national family health survey-5 (2019 - 2021)

    Spatial and spatio-temporal epidemiology

  2. Central obesity is associated with diabetes mellitus in humans (Adults living with HIV receiving ART) (AOR 3.27).

    “Central obesity (AOR = 3.27), detectable viral load (AOR = 4.2), hypertension (AOR = 4.95) and duration of ART >10 years (AOR = 3.12) were associated with diabetes.”

    HumansAdults living with HIV receiving ARTn = 520

    Prevalence of hypertension and diabetes and associated risk factors among people living with human immunodeficiency virus in Southern Ethiopia

    Frontiers in cardiovascular medicine

  3. Central obesity is associated with diabetes mellitus in humans (Normal BMI; adjusted for gender, age, and BMI) (PR 1.323 (95% CI 1.193–1.456)).

    “Hypertension, diabetes and hyperlipidemia were significantly associated with central obesity among adults with normal BMI”

    HumansNormal BMI; adjusted for gender, age, and BMI

    Prevalence of Central Obesity among Adults with Normal BMI and Its Association with Metabolic Diseases in Northeast China

    PloS one

  4. Central obesity is associated with diabetes mellitus in humans.

    “Hypertension, central obesity and hypertriglyceridaemia, but not hypercholesterolaemia were consistently associated with total diabetes.”

    Humans

    The Prevalence, Correlates, Detection and Control of Diabetes among Older People in Low and Middle Income Countries. A 10/66 Dementia Research Group Population-Based Survey

    PloS one

More on Diabetes mellitus

Cognitive impairment

downin humans2upin humans1OR 0.64–3.584

3 studies
  1. Central obesity is associated with cognitive impairment in humans (Indonesian older adults; adjusted for sociodemographic and health-related covariates) (OR 0.64, 95% CI 0.49–0.84).

    “obesity by BMI was inversely associated with cognitive impairment (OR = 0.56, 95% CI: 0.41-0.75), as was central obesity (OR = 0.64, 95% CI: 0.49-0.84).”

    HumansIndonesian older adults; adjusted for sociodemographic and health-related covariatesn = 1,495

    Obesity and Low Handgrip Strength as Contrasting Predictors of Cognitive Impairment in Indonesian Older Adults

    Geriatrics & gerontology international

  2. Central obesity is linked with a lower risk of cognitive impairment in humans (Chinese elderly) (RR = 0.86, 95% CI 0.81-0.91).

    “inverse associations were identified for central obesity defined by WC and WHR, with estimated effect sizes of 14% (RR = 0.86; 95%CI: 0.81-0.91)”

    HumansChinese elderly6 yearsn = 8,443

    A 6-year cohort study of the associations of body mass index, waist circumference, and waist-hip ratio with cognitive impairment in Chinese elderly

    Frontiers in psychology

  3. Central obesity is linked with a higher risk of cognitive impairment in humans (OR = 3.584).

    “BMI obesity and WC/WHR central obesity had a combined effect on the incidence of cognition impairment (OR = 3.076 and OR = 3.584).”

    Humans

    The association between body mass index, waist circumference, waist-hip ratio and cognitive disorder in older adults

    Journal of public health (Oxford, England)

More on Cognitive impairment

Multimorbidity

upin humans3HR 1.31

3 studies
  1. Central obesity is associated with multimorbidity in humans (Compared with individuals without NCDs; Model 1) (AOR 2.8, 95% CI 1.9–4.0).

    “Older age (≥ 45 years), female, central obesity, higher education, and employment in tertiary healthcare facilities were associated with increased odds of multimorbidity.”

    HumansCompared with individuals without NCDs; Model 1n = 2,881

    Prevalence, patterns, and correlates of non-communicable disease multimorbidity among healthcare workers: a multicenter study from Bangladesh

    BMC public health

  2. Central obesity is associated with multimorbidity in humans (Australian youth) (AOR = 1.27; 95% CI: 1.01-1.59).

    “central obesity was significantly associated with mental disorder (AOR = 1.25; 95% CI: 1.04-1.50), overall multimorbidity (AOR = 1.27; 95% CI: 1.01-1.59)”

    HumansAustralian youthn = 3,087

    Central obesity and its association with youth physical and mental health: evidence from the Australian National Health Survey

    BMC medicine

  3. Central obesity is linked with a higher risk of multimorbidity in humans (HR 1.31, 95% CI 1.08–1.61).

    “the HRs (95% CI) of the baseline BMI<24 kg/m2 and WC≥90 (men)/80 (women) group and BMI≥24 kg/m2 and WC≥90 (men)/80 (women) group were 1.31 (1.08, 1.61)”

    Humansn = 75,028

    Association of anthropometric indices with the development of multimorbidity in middle-aged and older adults: A retrospective cohort study

    PloS one

More on Multimorbidity

Physical inactivity

upin humans2OR 2.15

2 studies
  1. Physical inactivity is associated with central obesity in humans (Inner Regional areas) (OR 2.15, 95% CrI 1.73–2.69).

    “were physically inactive (OR = 2.15; 95% CrI: 1.73, 2.69), or had depression (OR = 1.96; 95% CrI: 1.49, 2.60) had higher odds of central obesity.”

    HumansInner Regional areas

    Central obesity in regional and remote Australian adults: a population-based Bayesian study

    BMC public health

  2. Physical inactivity is associated with central obesity in humans (AOR = 2.5 (95% CI: 1.4, 4.5)).

    “physical inactivity (AOR=2.5, 95% CI: 1.4, 4.5)”

    Humans

    Magnitude of Central Obesity and Its Associated Factors among Civil Servants in West Gojjam Zone District Government Offices, Northwest Ethiopia

    European Journal of Preventive Medicine

More on Physical inactivity

Age

upin humans2OR 1.16

2 studies
  1. Age is associated with central obesity in humans (Adjusted OR 1.16, 95% CI 1.08–1.25).

    “Age was positively associated with obesity at aOR=1.16 [95%CI: 1.08; 1.25], p<0.001.”

    Humansfemalesn = 104

    Association of Dietary Carboxy Methyl Lysine in Adult Women With Central Obesity: A Cross-Sectional Study

    Plexus Medical Journal

  2. Age is associated with central obesity in humans (AOR 5.07, 95%CI 3.34-7.68).

    “The odds of central obesity were significantly high among older adults aged 60 years and above (Adjusted Odds Ratio [AOR] = 5.07, 95%CI: 3.34-7.68)”

    Humans

    Gender disparities in central obesity in Cape Verde: analysis of the 2020 WHO STEPS survey

    Scientific reports

Older age

upin humans2

2 studies
  1. Older age is associated with central obesity in humans (AOR = 4.5 (95% CI: 2.3, 8.8)).

    “Factors positively associated with central obesity included older age (AOR=4.5, 95% CI: 2.3, 8.8)”

    Humans

    Magnitude of Central Obesity and Its Associated Factors among Civil Servants in West Gojjam Zone District Government Offices, Northwest Ethiopia

    European Journal of Preventive Medicine

  2. older age is associated with central obesity in humans.

    “A higher prevalence was found in older individuals, female subjects, urban residents, Caucasians, and populations of higher income level countries.”

    Review

    Global, regional and time-trend prevalence of central obesity: a systematic review and meta-analysis of 13.2 million subjects

    European journal of epidemiology

Moderate-to-vigorous physical activity

downin humans2OR 0.82

2 studies
  1. Moderate-to-vigorous physical activity is linked with a lower risk of central obesity in humans (substituting 30 min/day of sleep among individuals sleeping > 8 h/day).

    “Among individuals sleeping > 8 h/day, substituting 30 min/day of sleep with moderate-to-vigorous PA significantly reduced the risk of central obesity.”

    Humanssubstituting 30 min/day of sleep among individuals sleeping > 8 h/day30 min/day

    Joint Association of Sleep and Physical Activity with Central Obesity in Chinese Adults

    Biomedical and environmental sciences : BES

  2. Moderate-to-vigorous physical activity is linked with a lower risk of central obesity in humans (OR = 0.82, 0.71%-0.94%).

    “Meeting MVPA recommendations (≥ 600 MET-min/week) lowered prevalence by 18% (OR = 0.82, 0.71%-0.94%, p < 0.001).”

    Humans≥ 600 MET-min/weekn = 17,012

    Joint Association of Diet Index for Gut Microbiota and MVPA With Central Obesity: The Mediating Role of Biological Age

    Food science & nutrition

More on Moderate-to-vigorous physical activity

Dyslipidemia

upin humans2OR 1.545–2

2 studies
  1. Central obesity is linked with a higher risk of dyslipidemia in humans (OR=1.545, 95%CI: 1.365-1.748).

    “Individuals with central obesity had a 54.5% (OR=1.545, 95%CI: 1.365-1.748) higher risk compared with those without central obesity.”

    Humansn = 5,433

    Analysis on dyslipidemia and influencing factors in middle-aged and elderly people in Hainan Province

    Zhonghua liu xing bing xue za zhi = Zhonghua liuxingbingxue zazhi

  2. Central obesity is linked with a higher risk of dyslipidemia in humans (adjusted for confounding factors) (OR 2.00, 95% CI 1.62-2.46).

    “the risk of dyslipidemia in those with central and compound obesity was respectively 2.00 (95% CI 1.62-2.46) and 2.86 (95% CI 2.03-4.03) times higher”

    Humansadjusted for confounding factors

    Association between obesity and the prevalence of dyslipidemia in middle-aged and older people: an observational study

    Scientific reports

More on Dyslipidemia

Weight loss

upin humans1

1 study
  1. Central obesity predicts weight loss in patients treated with the VLCKD (Beta = 0.481; p = 0.005).

    “central obesity (Beta = 0.481; p = 0.005)”

    Human trialin patients treated with the VLCKDn = 34

    Predictors of weight loss in patients with obesity treated with a Very Low-Calorie Ketogenic Diet

    Frontiers in nutrition

All 88

Trial sponsors

Funding

3 grants since 2018

National Cancer Institute$196KWellcome Trust£2.1MHealth and Medical Research FundHK$275K

Latest

Dec 2025: 17Jan 2026: 32Feb 2026: 31Mar 2026: 38Apr 2026: 16May 2026: 6Jun 2026: 20Jul 2026: 22Aug 2026: 27Sep 2026: 30Oct 2026: 44Nov 2026: 27310 papers in 12 months

See all 709 papers on central obesity